Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.
2.

Predictors of aggressive therapy for nonmetastatic prostate carcinoma in Massachusetts from 1998 to 2002.

Rose AJ, Backus BM, Gershman ST, Santos P, Ash AS, Battaglia TA.

Med Care. 2007 May;45(5):440-7.

PMID:
17446830
3.

Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

Underwood W 3rd, Jackson J, Wei JT, Dunn R, Baker E, Demonner S, Wood DP.

Cancer. 2005 Feb 1;103(3):538-45.

4.
5.

Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.

Underwood W 3rd, Wei J, Rubin MA, Montie JE, Resh J, Sanda MG.

Urol Oncol. 2004 Jan-Feb;22(1):20-4.

PMID:
14969799
6.

Trends and black/white differences in treatment for nonmetastatic prostate cancer.

Klabunde CN, Potosky AL, Harlan LC, Kramer BS.

Med Care. 1998 Sep;36(9):1337-48.

PMID:
9749657
7.

Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.

Nieder AM, Porter MP, Soloway MS.

J Urol. 2008 Nov;180(5):2005-9; discussion 2009-10. doi: 10.1016/j.juro.2008.07.038. Epub 2008 Sep 17.

PMID:
18801517
8.

Treatment choice and quality of care for men with localized prostate cancer.

Miller DC, Spencer BA, Ritchey J, Stewart AK, Dunn RL, Sandler HM, Wei JT, Litwin MS.

Med Care. 2007 May;45(5):401-9.

PMID:
17446826
9.
10.

Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis.

Powell IJ, Dey J, Dudley A, Pontes JE, Cher ML, Sakr W, Grignon DJ, Wood DP.

Urology. 2002 Jun;59(6):907-12.

PMID:
12031379
11.

Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis.

Zeliadt SB, Penson DF, Albertsen PC, Concato J, Etzioni RD.

Cancer. 2003 Aug 1;98(3):496-503.

12.

Ethnic variation in health-related quality of life among low-income men with prostate cancer.

Krupski TL, Sonn G, Kwan L, Maliski S, Fink A, Litwin MS.

Ethn Dis. 2005 Summer;15(3):461-8.

PMID:
16108307
13.

Association of African-American ethnic background with survival in men with metastatic prostate cancer.

Thompson I, Tangen C, Tolcher A, Crawford E, Eisenberger M, Moinpour C.

J Natl Cancer Inst. 2001 Feb 7;93(3):219-25.

PMID:
11158191
14.

Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.

D'Amico AV, Hui-Chen M, Renshaw AA, Sussman B, Roehl KA, Catalona WJ.

J Urol. 2006 Dec;176(6 Pt 2):S11-5.

PMID:
17084157
15.

Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.

Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF.

Urology. 2004 Dec;64(6):1171-6.

PMID:
15596192
16.

Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study.

Hoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM.

Am J Med. 2006 May;119(5):418-25.

PMID:
16651054
17.

Marriage and ethnicity predict treatment in localized prostate carcinoma.

Denberg TD, Beaty BL, Kim FJ, Steiner JF.

Cancer. 2005 May 1;103(9):1819-25.

18.

Racial differences and prognostic significance of tumor location in radical prostatectomy specimens.

Tiguert R, Gheiler EL, Tefilli MV, Banerjee M, Grignon DJ, Sakr W, Wood DP Jr, Powell IJ, Pontes JE.

Prostate. 1998 Dec 1;37(4):230-5.

PMID:
9831219
19.
20.

Pathology of premalignant lesions and carcinoma of the prostate in African-American men.

Sakr WA, Grignon DJ, Haas GP.

Semin Urol Oncol. 1998 Nov;16(4):214-20. Review.

PMID:
9858328

Supplemental Content

Support Center